IPO registrations (S-1, F-1) · Registrants
Cyclo Therapeutics, Inc.
- SEC CIK
- 922247 · filings on EDGAR ↗
- Former names
- CTD HOLDINGS INC (2000–2019); CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC (1996–2000)
- Registration
- Form S-1, first filed 2005-01-06, last 2023-02-10; 5 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2020-12-11; declared effective 2019-07-12; withdrawal requested 2022-11-23
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- NV
- Business address
- 6714 NW 16TH STREET, SUITE B, Gainesville, FL 32653
- EIN
- 59-3029743
- EDGAR entity type
- operating
- Insiders and CEO pay
- Cyclo Therapeutics, Inc. on the corporate pages
Offering terms
- Final price
- $5.00 per share (424B4 filed 2020-12-11)
- Shares sold
- 2,500,000
- Gross proceeds
- $12,500,000 before underwriting discounts and any over-allotment option
- Listing
- OTCQB under the symbol CTDH
- Lead underwriters
- Maxim Group
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CYCLO THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: CYCLO THERAPEUTICS, INC. Fuzzy (name and state)
- Form D issuer: Cyclo Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: CTD HOLDINGS INC EXACT (CIK (EXACT))
- Person page: Joseph J Farnan Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: William S Shanahan Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 21
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-01-06 | S-1 | S-1 (registration) | CTD HOLDINGS INC | 0000922247-05-000002 ↗ |
| 2005-02-17 | S-1/A | S-1/A (amendment) | CTD HOLDINGS INC | 0000922247-05-000004 ↗ |
| 2019-06-27 | S-1 | S-1 (registration) | CTD HOLDINGS INC | 0001437749-19-012938 ↗ |
| 2019-07-12 | EFFECT | EFFECT (declared effective) | CTD HOLDINGS INC | 9999999995-19-001584 ↗ |
| 2020-09-29 | S-1 | S-1 (registration) | Cyclo Therapeutics, Inc. | 0001437749-20-020447 ↗ |
| 2020-11-16 | S-1/A | S-1/A (amendment) | Cyclo Therapeutics, Inc. | 0001437749-20-023999 ↗ |
| 2020-11-17 | S-1/A | S-1/A (amendment) | Cyclo Therapeutics, Inc. | 0001437749-20-024107 ↗ |
| 2020-12-04 | S-1/A | S-1/A (amendment) | Cyclo Therapeutics, Inc. | 0001437749-20-024798 ↗ |
| 2020-12-08 | EFFECT | EFFECT (declared effective) | Cyclo Therapeutics, Inc. | 9999999995-20-003433 ↗ |
| 2020-12-09 | S-1MEF | S-1MEF (added securities) | Cyclo Therapeutics, Inc. | 0001437749-20-025016 ↗ |
| 2020-12-11 | 424B4 | 424B4 (final prospectus) | Cyclo Therapeutics, Inc. | 0001437749-20-025127 ↗ |
| 2020-12-11 | 424B4 | 424B4 (final prospectus) | Cyclo Therapeutics, Inc. | 0001437749-20-025180 ↗ |
| 2021-05-28 | EFFECT | EFFECT (declared effective) | Cyclo Therapeutics, Inc. | 9999999995-21-002156 ↗ |
| 2022-10-31 | S-1 | S-1 (registration) | Cyclo Therapeutics, Inc. | 0001437749-22-025190 ↗ |
| 2022-11-21 | S-1/A | S-1/A (amendment) | Cyclo Therapeutics, Inc. | 0001437749-22-027806 ↗ |
| 2022-11-23 | RW | RW (withdrawal request) | Cyclo Therapeutics, Inc. | 0001437749-22-027975 ↗ |
| 2023-01-27 | S-1 | S-1 (registration) | Cyclo Therapeutics, Inc. | 0001437749-23-001977 ↗ |
| 2023-02-10 | S-1/A | S-1/A (amendment) | Cyclo Therapeutics, Inc. | 0001437749-23-002986 ↗ |
| 2023-02-13 | EFFECT | EFFECT (declared effective) | Cyclo Therapeutics, Inc. | 9999999995-23-000402 ↗ |
| 2023-11-21 | EFFECT | EFFECT (declared effective) | Cyclo Therapeutics, Inc. | 9999999995-23-003409 ↗ |
| 2024-06-04 | EFFECT | EFFECT (declared effective) | Cyclo Therapeutics, Inc. | 9999999995-24-001743 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-04 | S-1/A | registration statement | 2,300,000 | - | OTCQB CTDH | 1 | primary document; shares headline, cover names 1 | document ↗ | ||
| 2020-12-11 | 424B4 | final prospectus | $5.00 | 2,500,000 | $12,500,000 | OTCQB CTDH | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| TATE JEFFREY | Director; Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer; Chief Operating Officer; COO and CSO; COO & Chief Scientific Officer | 24 | 2010–2024 | |
| STRATTAN CE RICK | Director; Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 20 | 2010–2025 | |
| FINE N SCOTT | Director; Director,Officer | Chief Executive Officer | 32 | 2014–2024 | |
| Sieger Markus | Director | 38 | 2014–2025 | ||
| Ostronic Francis Patrick | Director | 54 | 2014–2025 | ||
| Fails George L | Director; Director,Officer | Executive Vice President | 3 | 2015–2017 | |
| Kusmierz Katarzyna | TenPercentOwner | 8 | 2015–2020 | ||
| NOVIT, L.P. | TenPercentOwner | 8 | 2015–2020 | ||
| Novit U.S., Inc. | TenPercentOwner | 8 | 2015–2020 | ||
| Farnan Joseph J Jr | Director | 8 | 2015–2019 | person page Fuzzy | |
| SHANAHAN WILLIAM S | Director | 25 | 2016–2025 | person page Fuzzy | |
| Toig Randall M. | Director | 23 | 2018–2025 | ||
| Hrynkow Sharon Hemond | Officer | Chief Scientific Officer; SVP for Medical Affairs | 12 | 2018–2021 | |
| Fine Joshua M | Officer | Chief Financial Officer | 9 | 2019–2024 | |
| ARMISTICE CAPITAL, LLC | TenPercentOwner | 8 | 2020 | ||
| Armistice Capital Master Fund Ltd. | TenPercentOwner | 8 | 2020 | ||
| Boyd Steven | TenPercentOwner | 8 | 2020 | ||
| Lisjak Michael Eric | Officer | Chief Regulatory Officer | 6 | 2020–2024 | |
| Kjems Lise Lund | Officer | Chief Medical Officer | 4 | 2021–2023 | |
| CONKLING WILLIAM | Director | 9 | 2023–2025 | ||
| Rafael Holdings, Inc. | TenPercentOwner | 4 | 2023–2025 | ||
| Wong Vivien | Director | 8 | 2023–2025 | ||
| Cross Shawn | Director | 6 | 2023–2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-09-03 | Cyclo Therapeutics, Inc. | Biotechnology | $3,000,000 | $2,831,114 | 19 | 1 |
| 2020-04-29 | Cyclo Therapeutics, Inc. | Biotechnology | $2,000,000 | $2,000,000 | 51 | 1 |
| 2019-06-05 | CTD HOLDINGS INC | Biotechnology | $7,442,500 | $7,442,500 | 50 | 1 |
| 2018-12-28 | CTD HOLDINGS INC | Biotechnology | $5,000,000 | $2,125,413 | 32 | 1 |
| 2017-10-27 | CTD HOLDINGS INC | Biotechnology | $5,000,000 | $1,500,000 | 26 | 1 |
| 2017-03-03 | CTD HOLDINGS INC | Biotechnology | $2,014,191 | $2,014,191 | 37 | 1 |
| 2016-06-13 | CTD HOLDINGS INC | Biotechnology | $2,000,000 | $2,000,000 | 23 | 1 |
| 2015-08-31 | CTD HOLDINGS INC | Biotechnology | $650,000 | $650,000 | 6 | 1 |
| 2015-07-23 | CTD HOLDINGS INC | Biotechnology | $1,300,000 | $1,300,000 | 5 | 1 |
| 2014-07-31 | CTD HOLDINGS INC | Biotechnology | $1,725,000 | $1,725,000 | 6 | 1 |
| 2014-04-22 | CTD HOLDINGS INC | Biotechnology | $1,000,000 | $1,000,000 | 1 | 1 |
| 2014-03-03 | CTD HOLDINGS INC | Biotechnology | $500,000 | $500,000 | 6 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CYCLO THERAPEUTICS, INC. | FL | State business registries | name and state |
| Business registration | CYCLO THERAPEUTICS, INC. | FL | State business registries | name and state |
| Form D issuer | Cyclo Therapeutics, Inc. | FL | Form D private offerings | CIK (EXACT) |
| Patent assignee | Cyclo Therapeutics, Inc. | FL | Patents (USPTO) | name and state |
| SEC filer | Cyclo Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Cyclo Therapeutics, Inc. | FL | Trademarks (USPTO) | name and state |
| Person page | Joseph J Farnan Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | William S Shanahan | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.